Recruiting SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection NCT03217617 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more Locations Shenzhen Geno-immune Medical Institute — Shenzhen, Guangdong, China View Trial Details
